JPH03291215A - Bathing liquid containing organic calcium - Google Patents
Bathing liquid containing organic calciumInfo
- Publication number
- JPH03291215A JPH03291215A JP2093020A JP9302090A JPH03291215A JP H03291215 A JPH03291215 A JP H03291215A JP 2093020 A JP2093020 A JP 2093020A JP 9302090 A JP9302090 A JP 9302090A JP H03291215 A JPH03291215 A JP H03291215A
- Authority
- JP
- Japan
- Prior art keywords
- solution
- bath
- powder
- acid
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 21
- 239000011575 calcium Substances 0.000 title claims description 21
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims description 20
- 229910052791 calcium Inorganic materials 0.000 title claims description 20
- 238000003287 bathing Methods 0.000 title abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 27
- 235000014653 Carica parviflora Nutrition 0.000 claims abstract description 17
- 241000243321 Cnidaria Species 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 12
- 239000001103 potassium chloride Substances 0.000 claims abstract description 6
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 6
- 239000011780 sodium chloride Substances 0.000 claims abstract description 6
- 238000007865 diluting Methods 0.000 claims abstract description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 36
- 239000000243 solution Substances 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract description 6
- 241000237509 Patinopecten sp. Species 0.000 abstract description 3
- 150000001735 carboxylic acids Chemical class 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 235000020637 scallop Nutrition 0.000 abstract description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 239000011975 tartaric acid Substances 0.000 abstract description 2
- 235000002906 tartaric acid Nutrition 0.000 abstract description 2
- 239000000644 isotonic solution Substances 0.000 abstract 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 229940043430 calcium compound Drugs 0.000 abstract 1
- 150000001674 calcium compounds Chemical class 0.000 abstract 1
- 239000001384 succinic acid Substances 0.000 abstract 1
- 238000010792 warming Methods 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 description 11
- 238000003756 stirring Methods 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000242757 Anthozoa Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- -1 carboxylic acid ions Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000036757 core body temperature Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000036387 respiratory rate Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- POZPMIFKBAEGSS-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;trihydrate Chemical compound O.O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O POZPMIFKBAEGSS-UHFFFAOYSA-K 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、冷え症、神経痛、古傷の痛み、肩凝り等の各
種疾患の治療用として、あるいは美肌維持、温浴効果向
上用として有効な、新規有機カルシウム浴用液に関する
ものである。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention provides novel organic calcium that is effective for treating various diseases such as sensitivity to cold, neuralgia, pain from old injuries, and stiff shoulders, as well as for maintaining beautiful skin and improving the effect of hot baths. It relates to bath liquids.
従来の孜術
これまで、硫黄、塩化ナトリウム、炭酸水素ナトリウム
、ホウ砂、ヨウ化ナトリウム、リン酸水素ナトリウム、
塩化アンモニウム、硫酸鉄などの無機物やメントール、
ショウノウ、種皮、ケイ皮、サリチル酸、オリーブ油、
酵素などの有機物を酸分とした人工温泉用浴剤は多数知
られている。また、その治療効果、温浴効果を高めたり
、皮膚への浸透を促進するために界面活性剤やキレート
化合物を配合したものも提案されている(特公昭31−
3699号公報、特公昭53−5382号公報)。Traditional medicine has been used in the past to include sulfur, sodium chloride, sodium hydrogen carbonate, borax, sodium iodide, sodium hydrogen phosphate,
Inorganic substances such as ammonium chloride and iron sulfate and menthol,
Camphor, seed coat, cinnabar, salicylic acid, olive oil,
Many artificial hot spring bath additives are known that contain organic substances such as enzymes as acids. In addition, products containing surfactants and chelate compounds have been proposed in order to enhance the therapeutic effect and hot bath effect, and to promote penetration into the skin (Special Publication No.
3699, Japanese Patent Publication No. 53-5382).
しかしながら、従来の人工温泉用浴剤や天然温泉に含ま
れる陰イオンは、炭酸水素イオン(ocot−)、塩素
イオン(CC−)、硫酸イオン(SO4”−)のような
無機イオンが主体であるため、人体に対する作用が強く
、体細胞の損傷、皮膚の炎症等を起こしやすい上に、共
存する多種多様の金属イオンとの間の相互作用により湯
疲れのような副作用を生じ、温度、濃度によっては、む
しろ人体に有害になるという欠点がある。However, the anions contained in conventional artificial hot spring bath additives and natural hot springs are mainly inorganic ions such as bicarbonate ions (ocot-), chloride ions (CC-), and sulfate ions (SO4''-). Therefore, it has a strong effect on the human body, easily causing damage to body cells and inflammation of the skin, and interactions with various coexisting metal ions can cause side effects such as fatigue in the hot water. actually has the disadvantage of being harmful to the human body.
発明が解決しようとする課題
本発明は、天然温泉や従来の人工温泉用浴剤がもつ欠点
を克服し、人体に対し、穏やかに作用し、しかも高い温
浴効果を奏する浴用液を提供することを目的としてなさ
れlこものである。Problems to be Solved by the Invention The present invention aims to overcome the drawbacks of bath additives for natural hot springs and conventional artificial hot springs, and to provide a bath liquid that acts gently on the human body and has a high hot bath effect. It was done for a purpose.
課題を解決するための手段
本発明者らは、長年にわたって温泉に含まれる溶解成分
とその作用との関係について種々研究を重ねた結果、温
泉における各種障害の原因が、主としてその中の適性量
を超えた量の無機陰イオンやアルカリイオンに起因する
こと、したがってこれを有機カルボン酸イオンや他の陽
イオンに変え、さらに最終の濃度を等供液相当濃度に調
節すればこれまでの障害を除去しうろこと及び天然産の
サンゴ及び貝殻がこの際の好適な陽イオン供給源となり
うろことを見い出し、これらの知見に基づいて本発明を
なすに至った。Means for Solving the Problems As a result of various research conducted over many years on the relationship between dissolved components contained in hot springs and their effects, the present inventors have found that the cause of various disorders in hot springs is mainly due to the inappropriate amount of dissolved components contained in hot springs. This is due to excessive amounts of inorganic anions and alkali ions. Therefore, by converting these to organic carboxylic acid ions or other cations and adjusting the final concentration to a concentration equivalent to that of the donor solution, the previous problems can be eliminated. We have discovered that scales and naturally occurring corals and shells are suitable sources of cations in this case, and based on these findings, we have accomplished the present invention.
すなわち、本発明は、サンゴ粉末又は貝殻粉末を有機カ
ルボン酸に溶解し、必要に応じ塩化ナトリウム及び塩化
カリウムの中から選ばれた少なくとも1種を添加したの
ち、水によりpH2,5ないし6.0を示す等供液濃度
まで希釈して戒る有機カルシウム浴用液を提供するもの
である。That is, the present invention dissolves coral powder or shell powder in an organic carboxylic acid, adds at least one selected from sodium chloride and potassium chloride as necessary, and then adjusts the pH to 2.5 to 6.0 with water. The present invention provides an organic calcium bathing solution that can be diluted to a concentration that shows the same concentration.
本発明においては、カルシウム供給源としてサンゴ粉末
又は貝殻粉末を用いることが必要である。In the present invention, it is necessary to use coral powder or shell powder as a calcium source.
これらの粉末は、いずれも動物自体の分泌物に由来する
ものであるため、その中の陽イオン組成は、人体に対し
て何ら障害を生じるおそれはない。Since all of these powders are derived from the secretions of the animals themselves, the cationic composition therein poses no risk of causing any harm to the human body.
このサンゴ及び貝殻の種類については特に制限はなく、
どのようなものでも用いることができるが、有効成分含
量が多く、供給量も豊富という点で、コーラルサンゴ、
かき殻、帆立貝殻などが好ましい。There are no particular restrictions on the types of corals and shells.
Although any substance can be used, coral coral,
Oyster shells, scallop shells, etc. are preferred.
また、本発明で用いる有機カルボン酸は、−塩基酸、多
塩基酸のいずれでもよく、酢酸、クエン酸、コハク酸、
酒石酸、シュウ酸、アスコルビン酸、乳酸、リンゴ酸な
どを用いることができるが、無色、無臭という点で特に
クエン酸が好ましい。Furthermore, the organic carboxylic acid used in the present invention may be either a -basic acid or a polybasic acid, such as acetic acid, citric acid, succinic acid,
Tartaric acid, oxalic acid, ascorbic acid, lactic acid, malic acid, etc. can be used, but citric acid is particularly preferred because it is colorless and odorless.
これらの有機カルボン酸は、サンゴ粉末又は貝殻粉末を
完全に溶解しうる濃度の水溶液として用いられる。この
濃度は、有機カルボン酸の種類や溶解しようとする粉末
の種類により変わるが、通常5%以上飽和濃度以下の範
囲である。These organic carboxylic acids are used in the form of an aqueous solution with a concentration that can completely dissolve coral powder or shell powder. This concentration varies depending on the type of organic carboxylic acid and the type of powder to be dissolved, but is usually in the range of 5% to saturated concentration.
本発明の有機カルシウム浴用液を調製するには、適当な
濃度をもつ有機カルボン酸水溶液にサンゴ粉末又は貝殻
粉末を加え、かきまぜることにより十分に溶解させる。To prepare the organic calcium bath solution of the present invention, coral powder or shell powder is added to an aqueous organic carboxylic acid solution having an appropriate concentration and stirred to sufficiently dissolve the powder.
この際、必要ならば加熱する二とによって溶解を促進す
ることもできる。このようにして得た溶液は、もしも不
溶の固体が存在する場合は、これを濾過して除き、また
所望ならば塩化ナトリウム又は塩化カリウムを加えたの
ち、等供液濃度すなわち体液と同じ滲透圧を示す濃度に
なるまで、水で希釈する。この際、希釈後の水溶液のp
Hが2,5ないし6.0の範囲内になるように調整する
。このように、等供液濃度まで希釈すること1こより、
滲透圧のアンバランスによる体細胞への悪影響を防止す
ることができる。At this time, dissolution can be promoted by heating if necessary. The solution thus obtained, after filtering off undissolved solids, if any, and adding sodium chloride or potassium chloride, if desired, is prepared at an isoconcentration, i.e., at the same osmotic pressure as the body fluid. Dilute with water until the concentration is as follows. At this time, the p of the aqueous solution after dilution is
Adjust so that H is within the range of 2.5 to 6.0. In this way, by diluting the solution to the same concentration,
It is possible to prevent adverse effects on body cells due to imbalance of osmotic pressure.
このようにして、調製した浴用液には、所望に応じさら
にクエン酸ナトリウムのような有機酸塩や香料、着色剤
、界面活性剤などを添加することができる。If desired, organic acid salts such as sodium citrate, fragrances, colorants, surfactants, etc. can be added to the bath liquid thus prepared.
次に、添付図面に従って、本発明の浴用液を温浴として
利用するのに好適なシステムの1例を説明する。Next, an example of a system suitable for using the bath liquid of the present invention as a hot bath will be explained according to the accompanying drawings.
図は、本発明の浴用液を利用するための浴場設備システ
ムの1例を示す系統図であって、溶解槽1で所定濃度の
有機カルボン酸水溶液にサンゴ粉末又は貝殻粉末を混合
し、溶解させて溶液を調製し、この溶液をポンプ2によ
り、濾過器3を経て貯蔵槽4に送り貯蔵する。次に、混
合槽5において貯蔵槽4からの有機カルシウム溶液と貯
蔵槽6からの塩化ナトリウム又は塩化カリウム水溶液と
を混合し、必要に応じ管路7から水を導入して、等供液
濃度の浴用液を調製するとともに、pHを2.5ないし
6.0の範囲内に調整する。このようにして調製した浴
用液は所要温度に加熱したのち、随時ポンプ8により浴
室内の浴[9へ供給する。The figure is a system diagram showing one example of a bath equipment system for using the bath liquid of the present invention, in which coral powder or shell powder is mixed and dissolved in an organic carboxylic acid aqueous solution of a predetermined concentration in a dissolution tank 1. A solution is prepared using a pump 2, and the solution is sent to a storage tank 4 via a filter 3 and stored therein. Next, in the mixing tank 5, the organic calcium solution from the storage tank 4 and the sodium chloride or potassium chloride aqueous solution from the storage tank 6 are mixed, and water is introduced from the pipe 7 as necessary to maintain the same concentration of the supplied solution. While preparing the bath solution, the pH is adjusted within the range of 2.5 to 6.0. The bath liquid thus prepared is heated to a required temperature and then supplied to the bath [9] in the bathroom by a pump 8 as needed.
この際、浴室内の湿度は、浴温か一定であっても、季節
、天候、建物構造への大気の影響、出入時の空気の移動
などIこより変動するが、本発明の有機力ルンウム浴用
液の効果を十分に発揮させるには、浴室内の湿度及び温
度をできるだけ一定に保つことが必要なので、温風機1
0を用い、45〜55℃程度に保った新鮮な乾燥空気を
常時送風循環させるのが有利である。At this time, even if the bath temperature is constant, the humidity in the bathroom fluctuates due to factors such as the season, the weather, the influence of the atmosphere on the building structure, and the movement of air when entering and exiting. In order to fully demonstrate the effect of the hot air fan, it is necessary to keep the humidity and temperature in the bathroom as constant as possible.
It is advantageous to constantly blow and circulate fresh, dry air maintained at about 45 to 55°C.
このようにすると、爽快感とともに、発汗が促進され、
温浴効果がより一層助長される。This will not only make you feel refreshed but also promote sweating.
The hot bath effect is further promoted.
発明の効果
本発明の有機カルシウム浴用液は、天然温泉や従来の人
工温泉浴剤に比べ、人体に対し穏やかに作用するので、
皮膚の損傷や体細胞への悪影響を生じることがなく、シ
かもすぐれた温浴効果を与えることができる。Effects of the Invention The organic calcium bath liquid of the present invention has a milder effect on the human body than natural hot springs or conventional artificial hot spring bath additives.
It does not cause skin damage or adverse effects on body cells, and it can provide an excellent hot bath effect.
また、特定の浴場設備システムと組み合わせて用いるこ
とにより、より一層その効果を高めることができる。。Moreover, by using it in combination with a specific bath equipment system, the effect can be further enhanced. .
実施例 次に、実施例により本発明をさらに詳細に説明する。Example Next, the present invention will be explained in more detail with reference to Examples.
実施例1
60℃の温湯iffにクエン酸509を加えて完全に溶
解させ、次いで純白サンゴ粉末(インドネシア、バリ島
産出)129を加えて30分間かきまぜた。この際、サ
ンゴ粉末は、二酸化炭素が発生し、泡立ちながら溶解し
た。Example 1 Citric acid 509 was added to 60°C warm water iff to completely dissolve it, then pure white coral powder 129 (produced in Bali, Indonesia) was added and stirred for 30 minutes. At this time, the coral powder generated carbon dioxide and dissolved while bubbling.
次に、不溶分を濾過して除き、45℃の温水200Qを
加えて希釈し、有機カルシウム浴用液を調製した。この
浴用液中のカルシウム濃度は22ppm。Next, insoluble matter was removed by filtration, and 200Q of 45° C. warm water was added to dilute the solution to prepare an organic calcium bath solution. The calcium concentration in this bath liquid was 22 ppm.
クエン酸濃度は243pp−であり、浴用液のpuは4
.2であった。The citric acid concentration is 243 pp-, and the pu of the bath solution is 4.
.. It was 2.
実施例2
サンゴ粉末の代りに帆立貝殻粉末logを用い、実施例
1と同様にして有機カルシウム浴用液を調製した。Example 2 An organic calcium bath liquid was prepared in the same manner as in Example 1, using log scallop powder instead of coral powder.
このようにして得た浴用液は、カルシウム濃度18pp
m1 クエン酸濃度238ppmを有し、pHは4.1
であった。The bath liquid thus obtained had a calcium concentration of 18 pp.
m1 has a citric acid concentration of 238 ppm and a pH of 4.1
Met.
実施例3
図面に示す浴場設備システムを用いて、実用的規模で有
機カルシウム浴用液を調製した。Example 3 An organic calcium bath liquid was prepared on a practical scale using the bath equipment system shown in the drawings.
すなわち、かきまぜ機を備えた0、51容量の溶解槽l
に60℃の温湯130Qを入れ、かきまぜながらクエン
酸14kgを加え完全に溶解させた。i.e. 0.51 capacity dissolution tank l equipped with a stirrer
130Q of 60°C warm water was added to the solution, and while stirring, 14 kg of citric acid was added and completely dissolved.
次にかきまぜを続けながら、サンゴ粉末5kgを徐々に
加え、溶解させ、さらに30分間かきまぜた。このよう
にして得た溶液を濾過器3を通して濾過し、不溶分を除
いたのち、0.31容量の貯蔵槽4に貯蔵した。Next, while continuing to stir, 5 kg of coral powder was gradually added, dissolved, and stirred for a further 30 minutes. The solution thus obtained was filtered through a filter 3 to remove insoluble matter, and then stored in a storage tank 4 with a capacity of 0.31.
別に、0.31容量の貯蔵槽6で、60℃の温湯100
Cとクエン酸ナトリウム・三水和物4kgと塩化カリウ
ム2kgを混合し、かきまぜて完全に溶解させlこ。Separately, in a storage tank 6 with a capacity of 0.31, 100 ml of hot water at 60°C is stored.
Mix C, 4 kg of sodium citrate trihydrate, and 2 kg of potassium chloride, and stir to completely dissolve.
次いで、11容量の混合槽5に、450℃の温湯44(
Mを入れ、この中へ貯蔵槽4からの溶液3512と貯蔵
槽6からの溶液25Qをかきまぜながら導入し、5分後
に浴槽8へ移した。この操作を4回繰り返し、約200
012の浴用液を調製した。浴槽中の浴用液のCa濃度
は11058pp%Na濃度は470ppmXK濃度は
516ppm、クエン酸濃度は7450ppm1CQ濃
度は458ppmであった。また、pt+は4.8であ
った。Next, 450°C hot water 44 (
Solution 3512 from storage tank 4 and solution 25Q from storage tank 6 were introduced into the tank while stirring, and after 5 minutes they were transferred to bathtub 8. Repeat this operation 4 times to obtain approximately 200
A bath solution of No. 012 was prepared. The Ca concentration of the bath liquid in the bathtub was 11058 ppm, the Na concentration was 470 ppm, the XK concentration was 516 ppm, the citric acid concentration was 7450 ppm, and the 1CQ concentration was 458 ppm. Moreover, pt+ was 4.8.
実施例4
かきまぜ機を備えた0、3−容量の溶解槽に45℃の温
湯200Qを入れ、かきまぜながらクエン酸9hgを加
え、完全に溶解させた。次にかきまぜながらサンゴ粉末
271gを徐々に加え溶解させt;後、この溶液を濾過
器を通して濾過し不溶分を除いて、有機カルシウム浴用
液を約20012調製した。この浴用液中のカルシウム
濃度は3980ppm、クエン酸濃FK ハ約40 、
000ppmであり、カルシウムとクエン酸の総合モル
濃度は0−30−3l1/ffであった。また、poは
3.4であった。Example 4 200Q of 45° C. hot water was put into a 0.3-capacity dissolution tank equipped with a stirrer, and 9 hg of citric acid was added while stirring to completely dissolve it. Next, while stirring, 271 g of coral powder was gradually added and dissolved; thereafter, this solution was filtered through a filter to remove insoluble matter, to prepare about 20,012 g of organic calcium bath liquid. The calcium concentration in this bath liquid is 3980 ppm, citric acid concentration FK is about 40,
000 ppm, and the total molar concentration of calcium and citric acid was 0-30-3 l1/ff. Moreover, po was 3.4.
実施例5
実施例1においてクエン酸の代りにリンゴ酸50gを用
いてサンゴ粉末12gを溶解し、この溶液から不溶分を
除去し、温水200Qを加えることにより有機カルシウ
ム浴用液を調製した。この浴中のカルシウム濃度は25
ppm、 リンゴ酸濃度は222ppmであり、浴
用液のpHは4.2であった。Example 5 In Example 1, 12 g of coral powder was dissolved using 50 g of malic acid instead of citric acid, the insoluble matter was removed from this solution, and 200 Q of warm water was added to prepare an organic calcium bath liquid. The calcium concentration in this bath is 25
ppm, the malic acid concentration was 222 ppm, and the pH of the bath solution was 4.2.
参考例
アルジョ社製介助浴槽に浴用液180Qを満たし、健常
若手男子6名を被験者とし3日間にわたって入浴効果を
調べた。Reference Example An auxiliary bathtub made by Arjo was filled with bath liquid 180Q, and the effects of bathing were investigated over 3 days using 6 healthy young men as subjects.
すなわち、食後2時間経過し、約30分間安静に保った
被験者を裸体で浴槽に入れ、半臥位で鎖骨が没する程度
の水位で7分間温浴を行ったのち、15分間安静状態に
置いた。かつ被験者の入浴は2回ずつ行い、2回目は2
4時間経過後とした。That is, two hours after eating, the subject was kept at rest for about 30 minutes, then placed naked in a bathtub, bathed in a warm bath for 7 minutes at a water level that submerged the collarbone in a semi-recumbent position, and then left at rest for 15 minutes. . And the subject took a bath twice, and the second time was 2 times.
This was done after 4 hours had passed.
この際の入浴条件は以下のとおりであった。The bathing conditions at this time were as follows.
室内気圧 954±15+ob
温度 71±5%
室温 35±1.7°C
浴温 38.5±0.7℃
測定は、日本光電社製ベツドサイドモニターライフスコ
ープ11、OMP −7201K 、日本電気三栄社製
エアロビクス、プロセッサー391−B、テルモ社製テ
ルモ電子血圧計及びサーモ・7アイナー・コア・テンプ
を用い、心拍数、酸素摂取量、分時換気■、呼吸数、血
圧、深部体温及び浮力感について行った。Room pressure: 954±15+ob Temperature: 71±5% Room temperature: 35±1.7°C Bath temperature: 38.5±0.7°C Measurements were made using Nihon Kohden Bedside Monitor Lifescope 11, OMP-7201K, NEC Saneisha Heart rate, oxygen intake, minute ventilation, respiratory rate, blood pressure, core body temperature, and buoyancy using Terumo aerobics, Processor 391-B, Terumo electronic blood pressure monitor, and Thermo 7-Einer Core Temp. went.
試料として、実施例3で調製した有機カルシウムを用い
て行った結果を以下に示す。The results obtained using the organic calcium prepared in Example 3 as a sample are shown below.
■)心拍数;
入浴と同時に上昇し最高51%に増加率が認められたが
出浴後は急速に安静時の水準に回復した。■) Heart rate: It increased at the same time as taking a bath, with an increase rate of up to 51%, but it quickly returned to the resting level after taking a bath.
2)酸素摂取量、分時換気量、呼吸数:入浴中もほぼ安
静時水準を維持し、特に変化は認められなかった。2) Oxygen intake, minute ventilation, and respiratory rate: They maintained almost their resting levels even during bathing, and no particular changes were observed.
3)血圧:
入浴後収縮期血圧で約10mmHg、拡張期血圧で約2
01RIIIHgの下降が認められ、入浴中その値が保
たれた。出浴後においては、拡張期血圧は入浴前の値に
戻ったが、収縮期血圧については、一部の被験者におい
て約10a+mHg高くなっていた。3) Blood pressure: After bathing, systolic blood pressure is approximately 10 mmHg, diastolic blood pressure is approximately 2
A decrease in 01RIIIHg was observed and this value was maintained during bathing. After taking a bath, diastolic blood pressure returned to the value before bathing, but systolic blood pressure was approximately 10 a+mHg higher in some subjects.
4)深部体温;
入浴直後から上昇し、足前、前額、手前の順で増加率が
高く、出浴後20分経過した時点でも発汗があり、入浴
前の値まで戻ることはなかった。4) Core body temperature: It rose immediately after taking a bath, and the rate of increase was highest in the front of the feet, forehead, and front of the body in that order.There was sweating even 20 minutes after taking a bath, and the temperature did not return to the value before bathing.
これは有機カルシウムを含まない通常の浴湯の場合と明
らかに異なっており、保温の持続効果を有することを示
している。This is clearly different from the case of ordinary bathing water that does not contain organic calcium, and shows that it has a sustained heat retention effect.
5)浮力廖;
通常の浴湯の場合に比べ浮力間及びリラックス感が著し
く、身体上部が水面上に露出しやすい傾向がみもれた。5) Buoyancy: Compared to regular bathing, the buoyancy and relaxation were significantly greater, and the upper part of the body was more likely to be exposed above the water surface.
図面は、本発明の浴用液を利用するの1こ好適な浴用設
備システムの1例を示す系統図であって、図中1は溶解
槽、3は濾過器、4,6は貯蔵槽、5は混合槽、8は浴
槽である。The drawing is a system diagram showing one example of a bath equipment system suitable for utilizing the bath liquid of the present invention, in which 1 is a dissolution tank, 3 is a filter, 4 and 6 are storage tanks, and 5 is a mixing tank, and 8 is a bathtub.
Claims (1)
、次いで水によりpH2.5ないし6を示す等張液濃度
まで希釈して成る有機カルシウム浴用液。 2 塩化ナトリウム及び塩化カリウムの中から選ばれた
少なくとも1種を含有させる請求項1記載の浴用液。[Scope of Claims] 1. An organic calcium bath solution prepared by dissolving coral powder or shell powder in an organic carboxylic acid, and then diluting the solution with water to an isotonic concentration having a pH of 2.5 to 6. 2. The bath liquid according to claim 1, which contains at least one selected from sodium chloride and potassium chloride.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2093020A JP2815457B2 (en) | 1990-04-10 | 1990-04-10 | Organic calcium bath liquid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2093020A JP2815457B2 (en) | 1990-04-10 | 1990-04-10 | Organic calcium bath liquid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03291215A true JPH03291215A (en) | 1991-12-20 |
JP2815457B2 JP2815457B2 (en) | 1998-10-27 |
Family
ID=14070804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2093020A Expired - Fee Related JP2815457B2 (en) | 1990-04-10 | 1990-04-10 | Organic calcium bath liquid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2815457B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06142643A (en) * | 1992-11-04 | 1994-05-24 | Kunio Hirota | Water purifying agent |
EP0699434A3 (en) * | 1994-07-05 | 1996-03-27 | Doetsch Grether & Cie Ag | |
FR2727862A1 (en) * | 1994-12-07 | 1996-06-14 | Holzmann Stephane | Cosmetic and/or dermatological compsn. |
JP6000490B1 (en) * | 2015-12-02 | 2016-09-28 | 健司 木山 | Bath additive |
-
1990
- 1990-04-10 JP JP2093020A patent/JP2815457B2/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06142643A (en) * | 1992-11-04 | 1994-05-24 | Kunio Hirota | Water purifying agent |
EP0699434A3 (en) * | 1994-07-05 | 1996-03-27 | Doetsch Grether & Cie Ag | |
FR2727862A1 (en) * | 1994-12-07 | 1996-06-14 | Holzmann Stephane | Cosmetic and/or dermatological compsn. |
JP6000490B1 (en) * | 2015-12-02 | 2016-09-28 | 健司 木山 | Bath additive |
Also Published As
Publication number | Publication date |
---|---|
JP2815457B2 (en) | 1998-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2948315B2 (en) | Dialysate generation system with dialysate pellets | |
CA2753110C (en) | Producing method for living organism-applicable hydgrogen-contained fluid and producing apparatus for the same | |
US4308255A (en) | Balanced oncotic pressure fluid | |
LIRWIN et al. | Acidosis and lacticacidemia in extracorporeal circulation: the significance of perfusion flow rate and the relation to preperfusion respiratory alkalosis | |
CN103796634B (en) | Dialysis precursor composition | |
US2035896A (en) | Liberation of oxygen from sodium perborate | |
Rabinovitch | Factors influencing the absorption of water and chlorides from the intestine | |
JPH03291215A (en) | Bathing liquid containing organic calcium | |
Keller Jr et al. | Perspiration interventions for conservative management of kidney disease and uremia | |
CN102302510A (en) | Medicinal composition and application thereof | |
ODAIRA | The influence of some neutral salt solutions, intravenously administered, on the reserve alkali of the blood | |
JP7034933B2 (en) | Dialysis concentrate | |
JPH01151462A (en) | Fluid for peritoneal perfusion | |
JPS6216409A (en) | Beautifying agent containing sodium chloride | |
JPH0334919A (en) | Bathing agent | |
RU2093142C1 (en) | Bath shampoo "legran" | |
Bahl | Studies on the Structure, Development, and Physiology of the Nephridia of Oligochaeta PART VIII: Biochemical Estimations of Nutritive and Excretory Substances in the Blood and Coelomic Fluid of the Earthworm and their Bearing on the Role of the Two Fluids in Metabolism | |
Keys | The properties of the gill membranes of fishes | |
JP2638088B2 (en) | Bath additive | |
CN104010645B (en) | Dialysis precursor composition | |
CN103998045B (en) | Dialysis precursor composition | |
JPH11189525A (en) | Bathing agent for foot | |
Meany | London Letter | |
Acid | MONTHLY SUMMARY. | |
Morris | On the Use of the Turkish Bath in Albuminuria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070814 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080814 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090814 Year of fee payment: 11 |
|
LAPS | Cancellation because of no payment of annual fees |